INS and Insulin resistance: In addition, systemic insulin resistance (i.e., elevated fasting blood glucose and insulin levels) is associated with the development of pulmonary arterial hypertension (Hansmann et al., 2007) and treatment with PIO abnormal pulmonary artery muscularization.